Advertisement

OB/GYN General

Women with Cervical Cancer and The Use of Hypnotics - A Population-Based Cohort Study

Sep 14, 2022

For a study, researchers sought to determine whether or not women who have been diagnosed with cervical cancer had a higher risk of using hypnotics, and we also found risk indicators for persistent us...

Survival Rates for Cervical Cancer Patients with FIGO Stage IVA

Sep 14, 2022

Cervical cancer in FIGO stage IVA is rare and carries a dismal prognosis. Overall survival (OS) in these patients is low despite the use of PET/CT for staging, concomitant treatment, and image-guided ...

Does Serum Human Epididymis Protein 4 (HE4) Support Referring an Ovarian Mass Patient to an Oncology Center?

Sep 14, 2022

For a study, researchers sought to evaluate the accuracy of human epididymis protein 4 (HE4) in distinguishing benign or borderline from malignant tumors in patients presenting to general hospitals wi...

Retroperitoneal Staging of Endometrial Cancer: Evaluating Long-Term Outcomes

Sep 14, 2022

In recent years, sentinel node mapping (SNM) has become increasingly popular as a treatment for clinically evident early-stage endometrial cancer (EC). Here, researchers looked at and examined how wel...

Adjuvant Chemotherapy Is Associated with Worse Survival for Patients with FIGO Stage I Epithelial Ovarian Carcinoma

Sep 14, 2022

One of the proposed quality metrics for patients with epithelial ovarian cancer  (EOC) is the provision of adjuvant chemotherapy within 42 days of surgery. The purpose of this research was to determi...

Measure of Ovarian Symptoms and Treatment (MOST) describes ovarian symptoms and Treatment

Sep 14, 2022

Patients with recurrent ovarian cancer (ROC) can evaluate the efficacy and safety of palliative chemotherapy by using the Measure of Ovarian Symptoms and Treatment (MOST) concerns; a validated patient...

The ORR with Pembrolizumab in KEYNOTE-158 Was 48% For Previously Treated MSI-H/Dmmr Endometrial Cancer (EC)

Sep 14, 2022

In the multicohort phase 2 KEYNOTE-158 study, pembrolizumab showed an objective response rate clinically significant in patients with advanced MSI-H/dMMR endometrial cancer who had had prior treatment...

In Patients with High-Risk Histologic Endometrial Cancer, Minimally Invasive Surgery Versus Open Surgery

Sep 14, 2022

For a study, researchers sought to evaluate the efficacy of minimally invasive surgery (MIS) versus open surgery (OPS) in reducing the risk of recurrence and death from endometrial cancer (EC) in pati...

Efficacy and Safety of Niraparib Plus Bevacizumab as First-Line Maintenance Therapy

Sep 14, 2022

For a study, researchers sought to evaluate the efficacy and safety of niraparib plus bevacizumab as a first-line maintenance treatment for patients with newly diagnosed advanced ovarian cancer. Patie...

The Efficacy and Safety of Pembrolizumab in Patients with Previously Treated Advanced Vulvar Squamous Cell Carcinoma

Sep 14, 2022

For a study, researchers sought to find a few alternatives for treating advanced vulvar carcinoma. Patients in phase 2 multicohort, open-label KEYNOTE-158 study with advanced vulvar squamous cell carc...

TCS Role in Recurrent Epithelial Ovarian Cancer

Sep 14, 2022

Tertiary cytoreductive surgery (TCS) for recurrent ovarian cancer was studied to determine its clinical efficacy. You can search MEDLINE, PubMed, Embase (Elsevier), ClinicalTrials.gov, Scopus (Elsevie...

ECC: LAVRH as a Safe Option for Minimal Invasive Surgery

Sep 14, 2022

Radical hysterectomy and pelvic lymphadenectomy were found to be the gold standard treatments for early-stage cervical cancer  (ECC) in a study. Recent prospective randomized trial results have spark...

Type of Cancer Treatment & Physical Activity with Psychosocial Outcomes

Sep 14, 2022

Although 1 study found a correlation between vigorous exercise and improved cancer survival, it was unclear which patients would reap the greatest benefits from taking up a more active lifestyle. Rese...

MOABP in Ovarian Cancer Debulking

Sep 14, 2022

Ovarian cancer patients who have their bowels removed as part of cytoreductive surgery (CRS) may benefit from a study looking into the aftereffects of this procedure using a combination of mechanical ...

Abdominal Closure Protocol and SSI After Hysterectomy

Sep 14, 2022

The purpose of this study was to examine the relationship between the use of a strategy for abdominal closure and the occurrence of surgical site infection (SSI) in gynecologic oncology patients under...

cN-/pN+ Vulvar Cancer Treatment: Declining Use of IFL

Sep 14, 2022

Researchers found that when sentinel lymph node biopsy (SLNB) results are positive despite clinically negative groin lymph nodes, there is controversy over how to treat vulvar cancer. Inguinofemoral l...

Cervical Cancer Patients Undergoing Surgical Treatment for Early-Stage Disease Are Protected by Preoperative Conization

Sep 13, 2022

The research was set out to determine whether or not pre-operative conization improved disease-free survival (DFS) in early-stage cervical cancer. This population-based cohort study used data from cli...

Seizure Frequency in Pregnancy More Likely With Focal Epilepsy

Aug 26, 2022

Women with focal epilepsy experienced the greatest risk for increased seizure activity in pregnancy and may require closer monitoring in pregnancy and the postpartum period.   “During...

Endometrial HLA-F Expression: Genotypes & Immune cell infiltration

Aug 10, 2022

Extravillous trophoblast cells express the immunomodulatory HLA class Ib molecules HLA-G and HLA-F, interacting with receptors on maternal immune cells. These molecules were found on extravillous trop...

Early Metabolomic Markers Can Predict Gestational Diabetes

Jul 25, 2022

Changes in pregnant women's blood were found in metabolites from early to mid-pregnancy that were linked with the risk for gestational diabetes in later pregnancy. “Gestational diabetes is ty...

SUBSPECIALTIES

Advertisement